Anti-Kickback Statute

The federal Anti-Kickback Statute (42 USC 1320a-7b) is a criminal statute that prohibits knowingly and willfully offering, paying, soliciting, or receiving any remuneration (direct or indirect, cash or in-kind) to induce or reward referrals for items or services payable by a federal healthcare program. Violations carry criminal penalties up to 10 years in prison and $100,000 per offense, civil monetary penalties, mandatory exclusion from federal programs, and treble damages under the False Claims Act when a tainted claim is submitted.

How the Anti-Kickback Statute works

AKS reaches any transaction where remuneration crosses between parties involved in a federal healthcare program transaction. The remuneration concept is broad: cash payments, gifts, discounts above safe harbor levels, free services, below-market rent, equity interests, speaker fees, consulting fees, and any other item of value can constitute remuneration. The intent element requires that at least one purpose of the remuneration be to induce referrals (Greber test, adopted by every circuit that has considered it). A transaction is not safe simply because it also has legitimate business purposes; the one-purpose test makes the analysis sharper than under Stark law.

Safe harbors at 42 CFR 1001.952 provide regulatory protection for specified transaction structures (investment interests in publicly traded entities, equipment rental, personal services and management contracts, sale of practice, referral services, warranties, discounts, employment, group purchasing organizations, electronic health records donations, and others). A transaction that fits within a safe harbor cannot be prosecuted under AKS. A transaction that does not fit a safe harbor is not automatically illegal; it is subject to a fact-specific analysis of the parties' intent.

When the Anti-Kickback Statute applies

AKS applies to any transaction involving an item or service that is or may be reimbursable by a federal healthcare program (Medicare, Medicaid, TRICARE, the VA, FEHB, and others). Transactions involving exclusively commercial business are not subject to AKS but may be subject to parallel state anti-kickback statutes and to the federal Eliminating Kickbacks in Recovery Act (EKRA) where laboratory or recovery services are involved.

The provider's exposure under the Anti-Kickback Statute

Criminal exposure includes felony conviction (up to 10 years), $100,000 per violation, and forfeiture. Civil exposure includes $100,000 per kickback under the Civil Monetary Penalties Law plus treble damages under the False Claims Act on every claim tainted by the AKS violation. Mandatory exclusion under 42 USC 1320a-7(a) follows a felony conviction, ending federal program participation. Practical exposure includes parallel state board action, license suspension, professional discipline, and reputational consequences in healthcare M&A diligence. The defense framework focuses on the intent element, safe harbor qualification, and the fact-specific structure of the disputed remuneration.

Related terms

• False Claims Act The civil statute that produces treble damages on every claim tainted by an AKS violation.
• Stark law The civil physician self-referral statute that addresses parallel conduct under a different (strict liability) framework.
• Qui tam The whistleblower mechanism through which most AKS-FCA cases reach DOJ.

See also

• Practice area
  Healthcare Fraud Defense

  The full healthcare fraud defense framework, including AKS, FCA, and parallel federal and state enforcement coordination.

• Practice area
  False Claims Act Defense

  Defense framework for FCA cases that incorporate AKS violations as the underlying basis for claim taint.

• Practice area
  Criminal Healthcare Fraud Defense

  Defense framework for criminal AKS prosecutions, including grand jury and indictment posture.